The US Bankruptcy Court granted an order for relief for liquidation under Chapter 7 for the involuntary petition filed against Generex Biotechnology Corp. on June 6, 2022. The debtor listed its assets of $338.41 million and liabilities of $521.63 million.
Generex Biotechnology Corporation
Equities
GNBT
US3714853013
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |